CompletedNCT03559426
Reducing or Stopping Antipsychotic Medication in Psychosis
About this title
Read the official source — NCT03559426Medication studyAges 18+United KingdomSchizophrenia
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- LondonSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: March 24, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 253
- Sponsor
- University College, London
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United Kingdom
- Age range
- Over 18 Years
- Official registry ID
- NCT03559426
- Official title
Show the full official title
Research Into Antipsychotic Discontinuation and Reduction (RADAR): A Randomised Controlled Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
London
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University College, London, a university.
Did this study involve medication?
Yes. The study involved medication, including Antipsychotic Reduction and Antipsychotic Maintenance.
Who was this study for?
Listed age limits: from 18 years.
